A Supreme Court case over whether to tighten restrictions on mifepristone – one of two drugs used in the medication abortion regimen – could destabilize the American pharmaceutical industry, deterring companies from developing new drugs and even inspiring copycat lawsuits intended to revoke authorization of other politically contentious medications. Read more at 19th News
“They’re not legitimate medical groups sounding an alarm. They’re ideological organizations, basically registering a website and using it to roll back reproductive rights,” Caroline Ciccone, president of the watchdog group Accountable.Us, said Thursday. “Basically, it’s a contrived coalition of extremist groups.” Read more at HuffPost
Adkins’ concerns go to the heart of a problem that has bedeviled scientists for at least a decade: the judicial system’s repeated adoption of poor-quality evidence to justify litigation and legislation to restrict abortion. Often that evidence is produced by the anti-abortion movement itself. Read more at The Guardian
Next week, the court will hear arguments in a case that could restrict the use of mifepristone, which a growing number of Americans get without an in-person appointment. Read more at 19th News
“We cannot ballot initiative our way out of this fundamental crisis of rights,” said Deirdre Schifeling, chief political and advocacy officer for the American Civil Liberties Union, one of many groups bracing for Trump and a Republican Congress to attempt to override state abortion protections. “I have no doubt that they would try to impose … Read more
He’s not talking about abortion much on the trail, but the former president has been a dependable ally of the anti-abortion movement and would have powers to act in a second term. Read more at 19th News
The Supreme Court on Monday set a date for one of the highest-stakes and closest-watched cases of the term — announcing it will hear oral arguments on how patients can access mifepristone, the commonly used abortion pill, on March 26. Read more at Politico
The appeals court ruling under review “threatens to destabilize the pharmaceutical industry, which relies both on FDA’s ability to make predictive judgments and on courts not second-guessing those scientific judgments,” the lawyers wrote. Read more at NBC News
Doctors across the country told The 19th that they have struggled to stay on top of the latest developments in abortion lawsuits since the Supreme Court’s decision in Dobbs v. Jackson Women’s Health Organization, which overturned federal abortion protections. That confusion, some said, could stop physicians even from providing legal pregnancy-related health care. Read more … Read more
People concerned about potential new abortion restrictions appear to be more likely to request abortion pills even if they’re not yet pregnant, according to a new analysis. Read more at National Public Radio, Inc.
